Form 8-K - Current report:
SEC Accession No. 0001193125-25-164789
Filing Date
2025-07-25
Accepted
2025-07-25 06:23:30
Documents
20
Period of Report
2025-07-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d20571d8k.htm   iXBRL 8-K 39098
2 EX-1.1 d20571dex11.htm EX-1.1 157081
3 EX-4.1 d20571dex41.htm EX-4.1 79965
4 EX-5.1 d20571dex51.htm EX-5.1 15445
5 EX-10.1 d20571dex101.htm EX-10.1 167138
6 EX-99.1 d20571dex991.htm EX-99.1 28768
7 EX-99.2 d20571dex992.htm EX-99.2 12245
11 GRAPHIC g20571dsp12.jpg GRAPHIC 5134
12 GRAPHIC g20571g0505105549782.jpg GRAPHIC 3130
  Complete submission text file 0001193125-25-164789.txt   764091

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20250724.xsd EX-101.SCH 2862
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20250724_lab.xml EX-101.LAB 17235
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20250724_pre.xml EX-101.PRE 10820
22 EXTRACTED XBRL INSTANCE DOCUMENT d20571d8k_htm.xml XML 3501
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 251148485
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)